業績集 2007
2011 | 2010 |
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993
| 1 | Lyshchik A., Higashi T., Asato R., Tanaka S., Ito J., Hiraoka M., Insana M. F., Brill A. B., Saga T., Togashi K.: Cervical Lymph Node Metastases: Diagnosis at Sonoelastography–Initial Experience., Radiology, 247(1):258-67, 2007 |
|
| 2 | Matsuo Y., Takayama K., Nagata Y., Kunieda E., Tateoka K., Ishizuka N., Mizowaki T., Norihisa Y., Sakamoto M., Narita Y., Ishikura S., Hiraoka M.: Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys, 68(2):416-25, 2007 |
|
| 3 | Kano H., Takahashi J. A., Katsuki T., Araki N., Oya N., Hiraoka M., Hashimoto N.: Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol, 84(1): 41-47, 2007. |
|
| 4 | Yamamoto T., Mizowaki T., Miyabe Y., Takegawa H., Narita Y., Yano S., Nagata Y., Teshima T., Hiraoka M.: An integrated Monte Carlo dosimetric verification system for radiotherapy treatment planning. Phys Med Biol, 52(7): 1991-2008, 2007 |
|
| 5 | Nagata Y., Matsuo Y., Takayama K., Norihisa Y., Mizowaki T., Mitsumori M., Shibuya K., Yano S., Narita Y., Hiraoka M.: Current status of stereotactic body radiotherapy for lung cancer., Int J Clin Oncol., 12(1): 3-7, 2007 |
|
| 6 | Hiraoka M., Matsuo Y., Nagata Y.: Stereotactic body radiation therapy (SBRT) for early-stage lung cancer, Cancer Radiother, 11(1-2): 32-5, 2007 |
|
| 7 | Zeng L., Kizaka-Kondoh S., Itasaka S., Xie X., Inoue M., Tanimoto K., Shibuya K., Hiraoka M: Hypoxia inducible factor-1 influences sensitivity to paclitaxel of human lung cancer cell lines under normoxic conditions., Cancer Sci., 98(9): 1394-401, 2007 |
|
| 8 | Hiraga T., Kizaka-Kondoh S., Hirota K., Hiraoka M., Yoneda T.: Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer., Cancer Res, 67(9): 4157-63, 2007 |
|
| 9 | Liu J., Harada H., Ogura M., Shibata T., Hiraoka, M.: Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts., Br J Cancer, 96(12): 1871-1878, 2007 |
|
| 10 | Kamino Y., Miura S., Kokubo M., Yamashita I., Hirai E., Hiraoka M., Ishikawa J.: Development of an ultrasmall C-band linear accelerator guide for a four-dimensional image-guided radiotherapy system with a gimbaled x-ray head., Med Phys., 34(5): 1797-1808, 2007 |
|
| 11 | Mitsumori M., Zhi-Fan Z., Oliynychenko P., Park J. H., Choi I. B., Tatsuzaki H., Tanaka Y., Hiraoka M.: Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency., Int J Clin Oncol., 12(3): 192-98, 2007 |
|
| 12 | Matsui K., Nagata Y., Hiraoka M. : Radiotherapy for Erdheim-Chester disease., Int J Clin Oncol., 12(3): 238-241, 2007. |
|
| 13 | Harada, H., Kizaka-Kondoh, S., Li, G., Itasaka, S., Shibuya, K., Inoue, M., and Hiraoka, M. Significance of HIF-1-active cells in angiogenesis and radioresistance. Oncogene, 26: 7508-7516, 2007. |
|
| 14 | Harada H., Kizaka-Kondoh S., Itasaka S., Shibuya K., Morinibu A., Shinomiya K., Hiraoka M.: The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts., Biochem Biophys Res Commun, 360(4):791-6, 2007 |
|
| 15 | Onishi H., Shirato H., Nagata Y., Hiraoka M., Fujino M., Gomi K., Niibe Y., Karasawa K., Hayakawa K., Takai Y., Kimura T., Takeda A., Ouchi A., Hareyama M., Kokubo M., Hara R., Itami J., Yamada K., Araki T.: Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study., J Thorac Oncol, 2(7 Suppl 3): S94-100, 2007 |
|
| 16 | Hiraoka M., Ishikura S.: A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer., J Thorac Oncol., 2(7 Suppl 3): S115-117, 2007 |
|
| 17 | Yoshimura K., Kamoto T., Nakamura E., Segawa T., Kamba T., Takahashi T., Nishiyama H., Ito N., Takayama K., Mizowaki T., Mitsumori M., Hiraoka M., Ogawa O.: Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy., Prostate Cancer Prostatic Dis., 10(3): 288-92, 2007 |
|
| 18 | Kamino Y., Tsukuda K., Kokubo M., Miura S., Hirai E., Hiraoka M., Ishikawa, J.: Development of a new concept automatic frequency controller for an ultrasmall C-band linear accelerator guide. Med Phys, 34(8): 3243-3248, 2007. |
|
| 19 | Yamauchi C., Mitsumori M., Sai H., Imagunbai T., Negoro Y., Sasaki Y., Hiraoka M., Shikama N., Sasaki S., Takegawa H., Inoue T., Teshima T.: Patterns of Care Study of Breast-conserving Therapy in Japan: Comparison of the Treatment Process between 1995-1997 and 1999-2001 Surveys., Jpn J Clin Oncol., 37(10):737-43, 2007 |
|
| 20 | Matsuo Y., Nagata Y., Mizowaki T., Takayama K., Sakamoto T., Sakamoto M., Norihisa Y., Hiraoka M.: Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. Int J Clin Oncol 2007. 12(5): p. 356-62. |
|
| 21 | Shibuya K, Komaki R, Shintani T, Itasaka S, Ryan A, Jurgensmeier JM, Milas L, Ang K, Herbst RS, O’Reilly MS. Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1534-43. |
|
| 22 | Wu W, Onn A, Isobe T, Itasaka S, Langley RR, Shitani T, Shibuya K, Komaki R, Ryan AJ, Fidler IJ, Herbst RS, O’Reilly MS. Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade. Mol Cancer Ther. 2007 Feb;6(2):471-83. |
|
| 23 | Itasaka S, Komaki R, Herbst RS, Shibuya K, Shintani T, Hunter NR, Onn A, Bucana CD, Milas L, Ang KK, O’Reilly MS. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):870-8. |